Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab bioavailability and pharmacodynamics in dermal interstitial fluid of atopic dermatitis
DRKS00023872Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dupilumab in atopic dermatitis (AD), sponsored by Medical University of Graz. Started Dec 2020; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on DRKS00023872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00023872.